0001770295-26-000007.txt : 20260603 0001770295-26-000007.hdr.sgml : 20260603 20260603160736 ACCESSION NUMBER: 0001770295-26-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260601 FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEBEL MARLENE CENTRAL INDEX KEY: 0001770295 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 261060651 MAIL ADDRESS: STREET 1: METLIFE, INC. STREET 2: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] ORGANIZATION NAME: 02 Finance EIN: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 4 1 wk-form4_1780517253.xml FORM 4 X0609 4 2026-06-01 0 0001099219 METLIFE INC MET 0001770295 DEBEL MARLENE false METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166 0 1 0 0 EVP & Chief Risk Officer 0 Common Stock 2026-06-01 4 M 0 10600 46.85 A 164980 D Common Stock 2026-06-01 4 M 0 10712 45.50 A 175692 D Common Stock 2026-06-01 4 S 0 21312 81.5889 D 154380 D Employee Stock Options (right to buy) 46.85 2026-06-01 4 M 0 10600 0 D 2027-02-27 Common Stock 10600 0 D Employee Stock Options (right to buy) 45.50 2026-06-01 4 M 0 10712 0 D 2028-03-01 Common Stock 10712 0 D The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020. The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021. /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact 2026-06-03